Literature DB >> 2114617

Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.

R L Semmes1, D D Shen.   

Abstract

The binding characteristics of valproic acid (VPA) and its pharmacologically active monounsaturated metabolite, E-delta 2-VPA, to rat plasma proteins were compared. The plasma free fraction was determined by a rapid equilibrium procedure, which minimizes the interfering effects of nonesterified fatty acids liberated by in vitro lipolysis. Nonlinear binding behavior was observed with both compounds over their respective pharmacologic concentration range. Multiple binding-site models were invoked to explain the binding isotherm. The 2-unsaturated compound has a much higher affinity for the rat plasma proteins (mainly albumin) than its saturated precursor. The equilibrium association constants for the high- and intermediate-affinity sites were more than an order of magnitude higher with E-delta 2-VPA than with VPA (10(4)-10(6) versus 10(3) M-1). This difference in binding affinity was also reflected by a lower plasma free fraction for E-delta 2-VPA compared with VPA (much less than 10 versus greater than 20% at total concentrations of less than 100 micrograms/ml). A more pronounced dose- and concentration-dependent variation in the distribution and clearance kinetics is predicted for the 2-unsaturated analogue compared to VPA. Also, the structural dependency in plasma protein binding observed with these branched-chain fatty acids may provide insights into the mechanism of interaction between fatty acyl molecules and albumin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114617     DOI: 10.1023/a:1015804413818

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.

Authors:  H Nau
Journal:  Teratology       Date:  1986-02

2.  Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.

Authors:  A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

3.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

4.  Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma.

Authors:  K M Giacomini; S E Swezey; J C Giacomini; T F Blaschke
Journal:  Life Sci       Date:  1980-09-01       Impact factor: 5.037

5.  Effect of initial conditions and drug-protein binding on the time to equilibrium in dialysis systems.

Authors:  P J McNamara; J B Bogardus
Journal:  J Pharm Sci       Date:  1982-09       Impact factor: 3.534

6.  Calculation of drug concentration in plasma after equilibrium dialysis.

Authors:  K M Giacomini; A Abang; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

7.  Valproic acid hepatic fatalities: a retrospective review.

Authors:  F E Dreifuss; N Santilli; D H Langer; K P Sweeney; K A Moline; K B Menander
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

8.  The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.

Authors:  T A Bowdle; I H Patel; R H Levy; A J Wilensky
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.

Authors:  R Riva; F Albani; A Baruzzi; I Galvani; E Perucca
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

10.  Valproate competes with palmitate for binding to serum albumin.

Authors:  H Vorum; S Andersen; R Brodersen
Journal:  Epilepsia       Date:  1989 May-Jun       Impact factor: 5.864

View more
  3 in total

1.  Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears.

Authors:  S Sato; S Kitagawa; M Nakajima; K Shimada; A Honda; H Miyazaki
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

2.  Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity-limited tissue distribution.

Authors:  H Y Yu; Y Z Shen
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

3.  Placenta transfer and toxicokinetics of valproic Acid in pregnant cynomolgus monkeys.

Authors:  Eun Ju Jeong; Wook-Joon Yu; Choong-Yong Kim; Moon-Koo Chung
Journal:  Toxicol Res       Date:  2010-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.